Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced/metastatic solid tumors.
0301 basic medicine
03 medical and health sciences
3. Good health
DOI:
10.1200/jco.2015.33.15_suppl.3005
Publication Date:
2019-03-07T22:17:57Z
AUTHORS (20)
ABSTRACT
3005 Background: Tumor associated macrophages (TAM) suppress anti-tumor immunity and have been associated with poor prognosis in several types of cancer. CSF-1 is a critical survival and differenti...
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (29)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....